MX2017014439A - Composicion para el tratamiento de parasitosis por gregarinas en camarones. - Google Patents
Composicion para el tratamiento de parasitosis por gregarinas en camarones.Info
- Publication number
- MX2017014439A MX2017014439A MX2017014439A MX2017014439A MX2017014439A MX 2017014439 A MX2017014439 A MX 2017014439A MX 2017014439 A MX2017014439 A MX 2017014439A MX 2017014439 A MX2017014439 A MX 2017014439A MX 2017014439 A MX2017014439 A MX 2017014439A
- Authority
- MX
- Mexico
- Prior art keywords
- gregarine
- infestation
- shrimp
- composition
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2015/053459 WO2016181187A1 (es) | 2015-05-11 | 2015-05-11 | Composición para el tratamiento de parasitosis por gregarinas en camarones |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017014439A true MX2017014439A (es) | 2018-03-02 |
Family
ID=57249567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017014439A MX2017014439A (es) | 2015-05-11 | 2015-05-11 | Composicion para el tratamiento de parasitosis por gregarinas en camarones. |
Country Status (4)
Country | Link |
---|---|
BR (1) | BR112017024363B1 (pt) |
EC (1) | ECSP17081673A (pt) |
MX (1) | MX2017014439A (pt) |
WO (1) | WO2016181187A1 (pt) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008009818A (es) * | 2008-07-31 | 2010-02-01 | Avi Mex S A De C V Lab | Combinacion coccidicida para uso veterinario. |
CN102575281B (zh) * | 2009-07-28 | 2014-11-19 | 日东纺绩株式会社 | 脱氢酶或对应的底物的测定方法及测定用试剂盒 |
-
2015
- 2015-05-11 MX MX2017014439A patent/MX2017014439A/es unknown
- 2015-05-11 WO PCT/IB2015/053459 patent/WO2016181187A1/es active Application Filing
- 2015-05-11 BR BR112017024363-6A patent/BR112017024363B1/pt active IP Right Grant
-
2017
- 2017-12-11 EC ECIEPI201781673A patent/ECSP17081673A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP17081673A (es) | 2018-02-28 |
WO2016181187A1 (es) | 2016-11-17 |
BR112017024363B1 (pt) | 2023-03-14 |
BR112017024363A2 (pt) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022000826A (es) | Composiciones de forma de dosificacion que comprenden un inhibidor de tirosina cinasa de bruton. | |
PH12018500284A1 (en) | 5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer | |
WO2016142855A3 (en) | Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors | |
NZ728392A (en) | High dosage strength tablets of rucaparib | |
TN2016000227A1 (fr) | Pyrrolo[2,3-d]pyrimidinyle, pyrrolo[2,3-b]pyrazinyle et pyrollo[2,3-d]pyridinyle acrylamides. | |
EA201890001A1 (ru) | Замещенные гетероциклические производные как ингибиторы циклинзависимой киназы (cdk) | |
PH12016501203A1 (en) | Crystalline forms of antiviral sofosbuvir analogues | |
EA201891315A1 (ru) | Твердые дисперсии, содержащие стимулятор sgc | |
PE20170189A1 (es) | Nuevos derivados de pirazolo pirimidina y su uso como inhibidores de malt1 | |
MX2017013219A (es) | Sales de maleato de un inhibidor de b-raf quinasa, formas cristalinas, metodos de preparacion y por consiguiente sus usos. | |
NZ710757A (en) | Methods of treating microbial infections, including mastitis | |
MX365313B (es) | Composición farmacéutica oral que comprende a,a,a-trifluorotimidin a y clorhidrato de 5-cloro-6-(2-iminopirrolidina-1-il)metil-2,4(1h ,3h)-pirimidina diona. | |
EP4249071A3 (en) | Benzoazepine analogs as inhibiting agents for bruton's tyrosine kinase | |
IL257872A (en) | Crystalline form of 2-(2,6-dichlorophenyl)-1-[(1s,3r)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1h)-yl]ethanone for the treatment of parkinson's disease | |
MY155922A (en) | Oral administrable pharmaceutical composition | |
RU2018115716A (ru) | Пиранодипиридиновое соединение | |
PE20160666A1 (es) | Derivados de etinilo | |
WO2018102670A3 (en) | Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock down | |
MX2017014439A (es) | Composicion para el tratamiento de parasitosis por gregarinas en camarones. | |
PH12015502661A1 (en) | (+)-5-(3,4-difluorophenyl)-5-[(3-methyl-2-oxopyridin-1(2h)-yl)methyl]imidazolidine-2,4-dione and drug containing same | |
WO2016167511A3 (ko) | N2-(2-메톡시페닐)피리미딘 유도체, 이의 제조 방법 및 이를 유효 성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물 | |
GT201700241A (es) | Composición para el tratamiento de parasitosis por gregarinas en camarones | |
PE20180328A1 (es) | Composicion para el tratamiento de parasitosis por gregarinas en camarones | |
PH12016502540A1 (en) | Pharmaceutical dosage forms | |
MX369874B (es) | Composicion farmaceutica para el tratamiento de la disfunción erectil a base de un farmaco inhibidor de la enzima pde-5 (fosfodiesterasa tipo 5) en gel. |